DiaMedica Therapeutics Inc. (DMAC)
USD 4.82
(-7.31%)
USD 4.82
(-7.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 500 Thousand |
| Cost of Revenue | 30 Thousand | 25 Thousand | 24 Thousand | 21 Thousand | 21 Thousand | - |
| Gross Profit | -30 Thousand | -25 Thousand | -24 Thousand | -21 Thousand | -21 Thousand | 500 Thousand |
| Operating Expenses | 21.26 Million | 14 Million | 13.64 Million | 12.49 Million | 10.73 Million | 6.04 Million |
| Selling, General and Administrative Expenses | 8.15 Million | 6.16 Million | 4.88 Million | 4.38 Million | 3.69 Million | 2.73 Million |
| Research and Development Expenses | 13.11 Million | 7.83 Million | 8.76 Million | 8.31 Million | 7.9 Million | 4.52 Million |
| Other Expenses | - | 353 Thousand | 82 Thousand | -205 Thousand | -856 Thousand | -68 Thousand |
| Cost and Expenses | 21.26 Million | 14 Million | 13.64 Million | 12.49 Million | 10.73 Million | 6.04 Million |
| Operating Income | -21.26 Million | -14 Million | -13.64 Million | -12.69 Million | -11.59 Million | -6.76 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 43 Thousand | 28 Thousand | 28 Thousand | 27 Thousand | 31 Thousand | 80 Thousand |
| Earnings before Tax | -19.33 Million | -13.64 Million | -13.56 Million | -12.26 Million | -10.61 Million | -5.65 Million |
| Net Income | -19.38 Million | -13.67 Million | -13.59 Million | -12.29 Million | -10.64 Million | -5.73 Million |
| Earnings Per Share Basic | -0.60 | -0.52 | -0.65 | -0.78 | -0.89 | -0.74 |
| Earnings Per Share Diluted | -0.60 | -0.52 | -0.65 | -0.78 | -0.89 | -0.74 |
| Weighted Average Shares Outstanding | 32.56 Million | 26.44 Million | 20.77 Million | 15.68 Million | 11.98 Million | 7.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.56 Million | 26.44 Million | 20.77 Million | 15.68 Million | 11.98 Million | 7.74 Million |
| Gross Margin | - | - | - | - | - | 1.00 |
| EBIT Margin | - | - | - | - | - | -10.99 |
| Profit Margin | - | - | - | - | - | -11.47 |
| EBITDA | -19.3 Million | -13.97 Million | -13.62 Million | -12.24 Million | -10.59 Million | -5.63 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -13.52 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 30.83 Million | - | - | - |
| Cost of Revenue | 10 Thousand | 8000.00 | 8000.00 | 30 Thousand | 5.15 Million | 4.74 Million |
| Gross Profit | -10 Thousand | -8000.00 | 30.83 Million | -30 Thousand | -5.15 Million | -4.74 Million |
| Operating Expenses | 5.62 Million | 5.74 Million | 5.84 Million | 21.23 Million | 5.15 Million | 4.74 Million |
| Selling, General and Administrative Expenses | 1.7 Million | 2.06 Million | 2.16 Million | - | 1.88 Million | 2.19 Million |
| Research and Development Expenses | 3.92 Million | 3.67 Million | 3.67 Million | - | 3.27 Million | 2.54 Million |
| Other Expenses | 526 Thousand | 597 Thousand | 709 Thousand | - | 693 Thousand | 271 Thousand |
| Cost and Expenses | 5.63 Million | 5.74 Million | 5.84 Million | 21.26 Million | 10.31 Million | 4.74 Million |
| Operating Income | -5.63 Million | -5.15 Million | -5.84 Million | -21.26 Million | -10.31 Million | -4.74 Million |
| Interest Expense | - | - | 5.76 Million | - | - | - |
| Income Tax Expense | 7000.00 | -7000.00 | 22 Thousand | 43 Thousand | -7000.00 | 7000.00 |
| Earnings before Tax | -5.11 Million | -5.14 Million | -5.13 Million | -19.33 Million | -4.46 Million | -4.47 Million |
| Net Income | -5.11 Million | -5.15 Million | -5.16 Million | -19.38 Million | -4.47 Million | -4.47 Million |
| Earnings Per Share Basic | -0.13 | -0.14 | -0.14 | - | -0.12 | -0.16 |
| Earnings Per Share Diluted | -0.13 | -0.14 | -0.14 | - | -0.12 | -0.16 |
| Weighted Average Shares Outstanding | 38.06 Million | 37.95 Million | 37.95 Million | 32.56 Million | 37.94 Million | 27.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.06 Million | 37.95 Million | 37.95 Million | 32.56 Million | 37.94 Million | 27.31 Million |
| Gross Margin | - | - | 1.00 | - | - | - |
| EBIT Margin | - | - | -0.19 | - | - | - |
| Profit Margin | - | - | -0.17 | - | - | - |
| EBITDA | -5.62 Million | -5.15 Million | -5.84 Million | - | -10.31 Million | -4.73 Million |
| Earnings Before Tax Margin | - | - | -0.19 | - | - | - |
SRFT
2491
2362
YSN
FIE
2270